MERCAPTOPURINE for Haematological malignancy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where MERCAPTOPURINE was used for Haematological malignancy.
Most Reported Side Effects for MERCAPTOPURINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 1,853 | 16.1% | 97 | 1,479 |
| Off label use | 893 | 7.8% | 95 | 290 |
| Pyrexia | 855 | 7.4% | 45 | 759 |
| Drug ineffective | 721 | 6.3% | 75 | 230 |
| Vomiting | 488 | 4.3% | 38 | 373 |
| Neutropenia | 485 | 4.2% | 41 | 335 |
| Nausea | 418 | 3.6% | 14 | 304 |
| Pneumonia | 394 | 3.4% | 160 | 202 |
| Pancytopenia | 392 | 3.4% | 66 | 258 |
| Sepsis | 389 | 3.4% | 96 | 268 |
| Abdominal pain | 367 | 3.2% | 14 | 223 |
| Bacterial infection | 365 | 3.2% | 267 | 61 |
| Anaemia | 357 | 3.1% | 17 | 265 |
| Diarrhoea | 352 | 3.1% | 22 | 222 |
| Febrile bone marrow aplasia | 308 | 2.7% | 8 | 302 |
Other Indications for MERCAPTOPURINE
Acute lymphocytic leukaemia (4,815)
Product used for unknown indication (1,136)
Crohn's disease (705)
Colitis ulcerative (512)
B precursor type acute leukaemia (484)
B-cell type acute leukaemia (308)
T-cell type acute leukaemia (251)
Chemotherapy (199)
Precursor t-lymphoblastic lymphoma/leukaemia (186)
Acute promyelocytic leukaemia (175)
Other Drugs Used for Haematological malignancy
RITUXIMAB (144)
CYCLOPHOSPHAMIDE (97)
FLUDARABINE (93)
BUSULFAN (80)
LENALIDOMIDE (71)
IBRUTINIB (62)
DOXORUBICIN (61)
BEVACIZUMAB (55)
GENOXAL INYECTABLE (49)
MYCOPHENOLATE (49)